App-Quantinova.ai

Under-referral of high risk asthma patients to specialist care in England

Chloe Bloom - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity

John Busby - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Objective cough count in bronchiectasis patients is reproducible and relates to quality of life

Angela Key - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Protocol to identify potential severe asthma in UK primary care

Heath Heatley - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A review of diagnoses made in a Severe Asthma Service

Emily Heiden - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Validation of the Danish version of the Bronchiectasis Health Questionnaire (BHQ)

Mikkel Hvass - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)

Abdi Ali - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The relationship between fractional exhaled nitric oxide and asthma symptom scores in patients on mepolizumab

David Jackson - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Glucocorticoid

The association between adherence and outcomes in severe asthma: a systematic review

Annabelle Culling - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Prevalence of nonadherence to controller therapy in adults with severe asthma – a systematic review and meta-analysis

Maged Hassan - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Physician and patient concordance of perceived asthma control: A US real world study

Anne Fuhlbrigge - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Association between COPD bronchial brush microbiome-determined ?Proteobacteria:Firmicutes (G:F) ratio and GOLD grade and symptoms

Mohammadali Yavari Ramsheh - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

EXhaled Hydrogen peroxide As a marker of Lung diseasE – the EXHALE 1A study

Matthew Jones - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

Hydrogen peroxide

Endotrophin and von Willebrand factor processing as predictive markers for mortality in the ECLIPSE COPD cohort

Jannie Sand - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Association between longitudinal changes in respiratory symptoms and lung mechanics in COPD

Emanuela Zannin - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Dyspnea

N/A

Does automated oxygen control with O2matic reduce frequency and duration of hypoxemic episodes in patients admitted with exacerbation of COPD? – a randomized controlled trial

Charlotte Sandau Bech - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Inspiratory capacity is associated with dyspnea, exercise capacity, and survival in COPD

Russell Buhr - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Dyspnea

N/A

Assessment of quality of life of bronchiectasis patients associated with asthma and COPD

Preetibala Vijay Kumar - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history

Jadwiga Wedzicha - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Tiotropium/olodaterol

Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients

Jadwiga Wedzicha - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Tiotropium/olodaterol

Filters

45280 Abstracts